Related Experiment Video
Updated: May 16, 2026

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
Published on: October 16, 2018
Evolution of HIV incubation times in AIDS patients
Y Román-Montoya1, A Bueno-Cavanillas, A M Lara-Porras
1Statistics and Operational Research, University of Granada, Campus de Fuentenueva, Spain. yroman@ugr.es
Insights
Highly active antiretroviral therapy (HAART) has reduced AIDS incidence. This study analyzed AIDS incubation times in Spain, finding longer incubation periods for women and intravenous drug users (IDU), associated with better survival outcomes.
Area of Science:
- Epidemiology
- Public Health
- Virology
Background:
- The incidence of Human Immunodeficiency Virus (HIV) infection remains largely unknown despite the decline in Acquired Immunodeficiency Syndrome (AIDS) cases due to highly active antiretroviral therapy (HAART).
- Understanding HIV incubation periods is crucial for public health interventions and patient management.
Purpose of the Study:
- To analyze AIDS incubation times in a large patient cohort within Spain's public health system.
- To investigate the evolution of mean incubation times based on transmission categories and demographic factors.
Main Methods:
- Analysis of 10,571 patient records from the Andalusian Register of Cases of AIDS (January 1981 to June 2008).
- Utilized survival and risk function analyses with R survival and DTDA libraries to determine AIDS incubation periods.
- Examined incubation time trends across different transmission routes (e.g., heterosexual, intravenous drug use) and demographic variables.
Main Results:
- A growing trend in mean viral incubation times was observed over the study period.
- Incubation periods were notably longer for women in heterosexual transmission cases.
- Intravenous drug users (IDU) exhibited the longest incubation periods.
- Both female gender and IDU transmission were linked to significantly greater survival without AIDS.
- Heterosexual transmission and pneumonia diagnosis were associated with reduced survival without AIDS.
Conclusions:
- AIDS incubation periods have evolved, with longer times observed in specific populations like women and IDUs.
- Transmission routes and co-diagnoses significantly impact both incubation duration and survival outcomes in HIV-infected individuals.
- Findings highlight the need for tailored public health strategies considering transmission dynamics and patient demographics.
Abstract:
Since introduction of highly active antiretroviral therapy (HAART), the incidence of AIDS has gradually declined, although the incidence of HIV infection is largely unknown. We have studied a sample with 10,571 patients whose data were recorded by Spain's public health system, in the Andalusian Register of Cases of AIDS. The diagnoses correspond to the period January 1981 to June 2008. For this period, AIDS incubation times were analyzed by means of the survival and risk functions, using R survival and DTDA libraries. We have studied the evolution of incubation mean times according to specific variables from database. The obtained results show that the mean times of viral incubation presented a growing trend that was greater among women when the study was limited to heterosexual transmission. Stratifying by category of transmission, the longest incubation period was seen for intravenous drug users (IDU). Both gender and IDU transmission were associated with significantly greater survival without AIDS. In contrast, heterosexual transmission or pneumonia diagnosis were associated with lower survival without AIDS.
Related Concept Videos
Retrovirus Life Cycles
Size and Structure of Viral Genomes
Viral Mutations
Sexually Transmitted Infections
